Polyethylene Glycol Versus Sodium Phosphate for Colon Preparation After Failure of First Preparation for Colonoscopy
NCT ID: NCT00558376
Last Updated: 2018-06-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
23 participants
INTERVENTIONAL
2008-01-31
2009-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Polyethylene Glycol Compared With Sodium Picosulphate for Bowel Preparation Before Colonoscopy
NCT01093274
Comparison of Bowel Cleansing Regimens Prior to Colonoscopy
NCT01649674
Multi-centre Failed Bowel Prep RCT
NCT02976805
Single Center Comparison of 4 FDA Approved, Commercially Available Bowel Purgatives for Colonoscopy
NCT02124447
Efficacy and Safety Study of Sodium Phosphate Tablets vs PEG for Bowel Cleansing
NCT01840553
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Ingestion of 3L polyethylene Glycol
polyethylene glycol
Single time 3 liters PEG, 250 cc every 15 minutes the day before colonoscopy
2
Ingestion of 2 doses of sodium phosphate 45 cc
Sodium phosphate
Sodium phosphate 45cc, 2 doses 4 hours apart the day before colonoscopy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
polyethylene glycol
Single time 3 liters PEG, 250 cc every 15 minutes the day before colonoscopy
Sodium phosphate
Sodium phosphate 45cc, 2 doses 4 hours apart the day before colonoscopy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to understand and sign an informed consent
* Preparation for frst colonoscopy consisted of sodium phosphate
Exclusion Criteria
* Chronic Renal Failure
* Allergy to any of the purgative ingredients
* Pregnancy
* Alcohol and/or drug abuse
* Vomiting or aspiration
* Suspected bowel obstruction
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sheba Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Shomron BenHorin
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shomron Ben-Horin, MD
Role: PRINCIPAL_INVESTIGATOR
Sheba Medical Center
Benjamin Avidan, MD
Role: PRINCIPAL_INVESTIGATOR
Sheba Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sheba_Medical_Center
Tel Litwinsky, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SHEBA-07-4884-SBH-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.